Discordance Between Cerebrospinal Fluid Biomarkers and Amyloid Positron Emission Tomography in Alzheimer’s Sheds Light on Clinical Trial Exclusion Criteria

Alzheimer’s disease (AD) is the most common type of dementia and affects millions of adults over the age of 60 years. Accurate diagnosis relies on multiple modalities, including neuropsychological testing, cerebrospinal fluid (CSF) biomarkers, and amyloid positron emission tomography (PET) imaging....

Descripción completa

Detalles Bibliográficos
Autores principales: Major, Catherine K, Okhravi, Hamid R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988618/
https://www.ncbi.nlm.nih.gov/pubmed/33777569
http://dx.doi.org/10.7759/cureus.13481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988618/
https://www.ncbi.nlm.nih.gov/pubmed/33777569
http://dx.doi.org/10.7759/cureus.13481

Ejemplares similares